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Ethno-pharmacological relevance: Chenopodium ambrosioides (Amarantaceae) is an annual or perennial
plant popularly known as ‘erva de Santa Maria’, ‘mastruc-o’ and ‘erva-do-formigueiro’. This herb is used
in folk medicine in the form of teas, poultices and infusions for inﬂammatory problems, contusions and
lung infections, and as an anthelmintic and anti-fungal.
Aim of the study: The aim of the present study was to further the understanding of the anti-nociceptive,
anti-inﬂammatory and wound healing effects of ethanol extract (EE) obtained from the leaves and
stems of Chenopodium ambrosioides in animal models of acute pain, inﬂammation and wound healing,
thus supporting its medicinal use for the treatment of pain and inﬂammatory conditions
Materials and methods: The anti-nociceptive activity of EE (150–500 mg/kg) was evaluated using the
nociception induced by formalin (2.5%), prostaglandin-E2 (PGE2; 3 nmol/paw), capsaicin (CAP, 1.6 mg/paw)
and bradykinin (BK, 10 nmol/paw). The anti-inﬂammatory activity of EE (150–500 mg/kg) was evaluated in
carrageenan- (Cg, 300 mg/paw), PGE2- (3 nmol/paw), substance P- (SP, 20 nmol/paw) and BK- (3 nmol/paw)
induced paw oedema. The topical anti-inﬂammatory activity of EE (1%, 3% and 5%) was evaluated in
arachidonic acid- (AA, 2 mg/ear), oil croton- (1 mg/ear) and CAP- (250 mg/ear) induced ear oedema. The effect
of this extract in the inhibition of the inﬂux of neutrophil, myeloperoxidase (MPO) and adenosine-deaminase
(ADA) activities and nitric oxide (NO) and TNF-a´ levels was also determined using the mouse of pleurisy
induced by Cg. The excision wound model in rats was used to evaluate the wound healing efﬁcacy of EE (1%,
3% and 5%). To exclude the possible non-speciﬁc muscle relaxant or sedative effects of EE, mice motor
performance was also evaluated with the rota-rod test.
Results: EE (5% per ear) was effective in reducing ear oedema induced by croton oil by 78.09%, CAP by
70.85% and AA by 77.02%. EE (500 mg/kg; p.o.) also signiﬁcantly inhibited paw oedema induced by Cg by
40%, PGE2 by 51%, SP by 56% and BK by 57%. EE (500 mg/kg; p.o.) inhibited the cell inﬂux of leucocytes by
78% and neutrophils by 53%, MPO activity by 62.22% and ADA activity by 23.07%, as well as NO by 77.77%
and TNF-a´ levels by 50% in the ﬂuid leakage due to the carrageenan-induced pleurisy. EE also inhibited the
formalin-induced nociceptive in both phases of pain (neurogenic and inﬂammatory) at a dose of 500 mg/kg,
resulting in inhibitions of 77.39% and 95.60%, respectively. EE (500 mg/kg; p.o.) was also effective in
inhibiting the nociception induced by PGE2 (68%), CAP (53%) and BK (32%). Topical application of EE (5%) on
excision wounds caused a signiﬁcant reduction in wound area when compared with the untreated controls.
Finally, treatment with EE (150–500 mg/kg) did not show any signiﬁcant alterations in motor performance
or body temperature compared with the control group.
Conclusions: The results, including the inhibition of mediators (BK, NO, SP, PGE2 and TNF-a´) and enzyme
(MPO and ADA) activity, validate the use of the plant under study for therapeutic treatment of anti-
inﬂammatory, painful and wound healing processes.
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In Brazil, many medicinal plants provide relief comparable to
that of conventional medicinal agents in the treatment of differ-
ent diseases, and they contain new bioactive molecules. The
biodiversity present in different regions of the country is a
potential source of bioactive compounds (Kinsgton, 2011).
Recently, the Brazilian government launched a programme
known as the National List of Plants of Interest to the (RENISUS),
which lists 71 plants used with emphasis on Brazilian folk
medicine. The programme aims to support phytotherapy as an
alternative treatment of diseases and also encourage Brazilian
researchers to validate the pharmacological properties of these
plants, including their efﬁcacy and safety (Brasil, 2008). It is impor-
tant to note that Chenopodium ambrosioides (L) (Amaranthaceae)
belongs to this list.
Chenopodium ambrosioides (L) is an annual or perennial plant
with a strong aromatic odour and can grow up to 1 m tall. It is
native to Central and South America that adapts to diverse
conditions and is considered invasive. In Brazil, this species has
a wide distribution, occurring in almost every territory. It is
popularly known as ‘erva de Santa Maria’, ‘mastruc-o’ and ‘erva-
do-formigueiro’(Lorenzi and Matos, 2002). In Brazilian folk med-
icine, the plant is crushed and served in the form of teas, infusions
or poultices for several purposes: it acts as a diuretic and an
anthelmintic, and it is used to treat wounds, respiratory problems,
inﬂammatory and painful processes, bronchitis, tuberculosis and
rheumatism (Kumar et al., 2007).
Phytochemical investigations revealed that the plant contains
terpenes, sterols and phenols (Kokanova-Nedialkova et al., 2009).
The monoterpene ascaridole is the main component of essential
oil. This compound has sedative, and anthelmintic effects (Olajide
et al., 1997; Efferth et al., 2002). Ibironke and Ajiboye (2007)
demonstrated in a preliminary study that methanol extract of the
leaves of Chenopodium ambrosioides (L) has anti-inﬂammatory and
anti-ociceptive properties. Considering the importance of Chenopo-
dium ambrosioides (L) to Brazilian folk medicine, the aim of this study
was to investigate in more depth the anti-inﬂammatory, anti-
nociceptive and healing properties of the ethanol extract (EE) of the
leaves and stems of this specimen in animal models.2. Materials and methods
2.1. Collection and authentication of plant material
The aerial parts (stems and leaves) of Chenopodium ambro-
sioides (L) were collected in March 2010 in Ca´ceres, a city in the
state of Mato Grosso, Brazil. The plant was dried at room
temperature and protected from light and sun. Taxonomic iden-
tiﬁcation of the collected material was done by comparison with
the proved samples that was analysed by botanist M.Sc. Oscar
BenignoIza and deposited in the Herbarium Barbosa Rodrigues
(HBR), Itajaı´, SC (number 52802).2.2. Preparation of extract and puriﬁcation of active compounds
The dried vegetal material (leaves, 2.22 kg and stems, 1.24 kg)
of Chenopodium ambrosioides (L) was crushed and macerated with
100% ethanol (12 L) at room temperature for 7 days. Solvent
removal was carried out under reduced pressure at temperatures
below 45 1C until the desired concentrations were achieved with
dried leaves (48.44 g) and stems (24.42 g). The extracts were
combined due to similar chromatographic proﬁles evaluated
through thin layer chromatography (TLC).A portion of the ethanol extract (EE) of the leaves and stems
(9.37 g) was subjected to column chromatography (CC) using
silica gel 60 as the stationary phase and eluted with hexane (Hex)
and increasing the polarity with ethyl acetate (EtOAc) and ending
with methanol. In total, 122 fractions(20 ml each) were collected
and analysed by TLC. The fraction eluted with Hex:EtOAc(95:5)
designate 1 was submitted to 1H and 13C nuclear magnetic
resonance (NMR) analysis.
The fraction 131–154 (811.67 mg) eluted with Hex:
EtOAc(60:40) was submitted to column chromatography packed
with silica gel. Fraction 15 eluted with Hex:EtOAc 70:30 designate
2 as submitted to NMR analysis.
2.3. Animals
Experiments were carried out using male Swiss mice(20–30 g),
with an exception for wound-healing experiments in which
Wistar rats were used (200–250 g). The animals were kept at
controlled room temperature (2273 1C) under a 12 h:12 h light-
dark cycle (lights on at 0600 h), with access to water and food ad
libitum. The animals were acclimatised to the laboratory 1 h
before testing and were used once throughout the experiments.
All procedures used in the present study were approved by the
Institutional Ethics Committee of UNIVALI (037/2009CEP/UNI-
VALI) and were carried out in accordance with the current
guidelines for the care of laboratory animals and the ethical
guidelines for investigations of experimental inﬂammation and
pain in conscious animals (Zimmermann, 1983). The number of
animals (N¼6–8) and the intensity of noxious stimuli used were
the minimum necessary to demonstrate the consistent effects of
the herb treatment. The doses used in the study were lower than
those that produce toxic effects.
2.4. Drugs and reagents
The following substances were used: croton oil, arachidonic
acid (AA), capsaicin (CAP), bradykinin (BK), prostaglandin (PGE2),
grade IV lambda carrageenan (Cg), substance P (SP), captopril,
indomethacin, myeloperoxidase, sodium azide, adenosine
phosphate-buffered solution, adenosine, phenol, sodium nitro-
prussiate, the alkaline buffer NaOCl, naphthyl ethylendiamide
dihydrochloride, sulphanilamide, phosphoric acid, vanadium
chloride and dexamethasone; all substances were obtained from
Sigma Chemical Co. (St Louis, MO, USA). Formaldehyde was
obtained from Chemical Ind. e Com. (SP, Brazil), HeparinTM
(Roche, Brazil), Evans blue and Tu¨rk solution (Merck, Rio de
Janeiro, Brazil), May-Grunwald (Newprov, Pinhais PR, Brazil),
and Giemsa (Laborclin, Pinhais, PR, Brazil) were also used. The
enzyme-linked immunosorbent assay (ELISA) for quantitative
determination of mouse TNF-a was from BD Biosciences Phar-
mingen (San Diego, CA, USA). The drugs and extracts were
dissolved in saline (vehicle), except capsaicin, which was dis-
solved in absolute ethanol. All doses and routes of administration
of the Chenopodium ambrosioides (L) materials were chosen in
accordance with previously established protocol based on our
pilot experiments (unpublished data).
2.5. Determination of anti-inﬂammatory effect of Chenopodium
ambrosioides(L)
2.5.1. Effect of Chenopodium ambrosioides (L) in ear oedema
induced by different phlogistic agents
The oedema was expressed as an increase in ear thickness due
to inﬂammation. Ear thickness was measured before and after
induction of the inﬂammatory response using a micrometre
(Mitutoyo Series 293). The micrometre was applied near the tip
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was recorded in millimetre. To minimise variation in technique, a
single investigator performed the measurements throughout each
experiment (Zanini et al., 1992).
The animals received the cream with EE of the leaves and
stems of Chenopodium ambrosioides (L) at different concentrations
(1%, 3% and 5%) in the inner surface of the right ear. Another
group of animals received dexamethasone cream (1%, positive
control), and another received only the base (cream without
active compounds, negative control). After 30 min of treatment,
each animal received 20 ml croton oil (1 mg/ear), capsaicin
(250 mg/ear) and arachidonic acid (AA, 2 mg/ear) on the outside
face of the right ear. The ear oedema was assessed 30 min, 60 min
and 6 h after application of capsaicin, arachidonic acid or croton
oil, respectively. The difference between the ear thickness from
the baseline (before application of the phlogistic agents) and after
induction of oedema was expressed in millimetre and taken as an
indication of oedema.
2.5.2. Effect of Chenopodium ambrosioides (L) on paw oedema
induced by different phlogistic agents
The paw oedema experiments were conducted in accordance
with Busnardo et al. (2010) with some modiﬁcations. Oedema
was induced in the right hind paw with a 20-ml intraplantar (i.pl.)
injection of Cg (300 mg/paw), SP (20 nmol/paw), PGE2(3 nmol/paw),
or BK (3 nmol/paw). The contra-lateral paw (left paw) received the
same volume of saline and was used as the negative control. In this
experiment with bradykinin, the animals were pretreated with
captopril (5 mg/kg s.c.) 1 h prior to BK induction to prevent BK
degradation. Depending on the phlogistic agent used in the experi-
ment, the measurement of oedema was made with a plethysm-
ometer (UgoBasile, Italy) at different time points after its injection.
Oedema was expressed as the difference between the right and
left paws.
The paw oedema was assessed in mice previously treated by
oral gavage (p.o.) with EE (150, 300 and 500 mg/kg) or indo-
methacin (10 mg/kg, p.o.), 1 h before injection of the phlogistic
agent.
2.5.3. Pleurisy
Pleurisy was conducted in mice previously treated by oral
gavage (p.o.) with EE (150, 300 and 500 mg/kg) or indomethacin
(10 mg/kg, p.o.), 1 h before carrageenan injection.
The animals were lightly anaesthetised with ethyl ether and
after mild anaesthesia, Cg (300 mg/cavity) was injected into the
right pleural cavity. The animals were sacriﬁced 4 h after the Cg
injection. Immediately, the thorax was opened, the pleural cavity
was washed with 1 ml saline (NaCl 0.9%) plus heparin (20 IU/ml),
and the exudate was collected (Busnardo et al., 2010). Total cell
counts were performed in Neubauer chambers by means of an
optical microscope (magniﬁcation 40 ) after diluting a sample of
the collected ﬂuid from the pleural space with Tu¨rk solution
(1:40). Cellular smears were prepared with an aliquot of pleural
lavage to determine the differential leucocyte count. The slides
were stained with May-Gru¨nwald-Giemsa dye, and the analysis
was carried out under oil immersion objective.
Another sample of the pleural cavity ﬂuid was used to evaluate
the myeloperoxidase and adenosine desaminase activity and the
NO and TNF-a levels.
2.5.4. Quantiﬁcation of MPO and determination of ADA activities
in Cg-induced pleurisy
MPO and ADA were performed in accordance with the meth-
ods described by Dalmarco et al. (2002). Pleural cavity ﬂuid
samples and standards were transferred to cuvettes, and thereaction was initiated with the addition of 360 ml of assay buffer,
the reaction was stopped with 1% sodium azide. Afterwards, the
samples were centrifuged at 50 g for 5 min at room temperature
(22–25 1C ). The supernatants were separated, and the concentra-
tion of the enzyme was estimated by colorimetric measurement
(absorbance at 450 nm) in an ELISA plate reader (Organon
Technical, Roseland, NJ, USA). The results were expressed as
mU/ml.
The test of ADA activity pleural cavity ﬂuid samples were
transferred to cuvettes, and the reaction was initiated with the
addition of adenosine phosphate-buffered solution. After incuba-
tion for 1 h at 37 1C, the reaction was halted with the addition of a
solution of phenol, nitroprusside and alkaline buffer. This solution
was also added to the cuvettes with the different standard
samples. The concentration of the enzyme was estimated by
colorimetric measurements (absorbance, 620 nm) in an ELISA
plate reader (Organon Technical, Roseland, NJ, USA). The results
were expressed as U/L, and the experiments were done in
duplicate.2.5.5. Quantiﬁcation of TNF-a and nitric oxide levels in carrageenan-
induced pleurisy
The measurements of levels of TNF-awere evaluated using the
method previously described by Dalmarco et al. (2002). After the
4-h pleurisy procedure, the animals were sacriﬁced, and the
exudate samples were collected and stored at 70 1C. The pleural
ﬂuid recovered was centrifuged at 770 g for 10 min (room
temperature), and the cell-free supernatant was quantiﬁed for
TNF-a contents by ELISA (NuncMaxsorp). Quantiﬁcation was
performed using a microplate reader at absorbance of 490 nm.
NO was measured as its breakdown products nitrite (NO2
) and
nitrate (NO3
) using the Griess method. Pleural cavity ﬂuid
samples (0.1 mL) were transferred to cuvettes, and vanadium
chloride 0.05 M (0.15 mL) in HCl 1.0 M (0.05 mL) was added to
reduce nitrate to nitrite. Immediately, Griess reagent [150 UL of
naphthyl ethylendiamide dihydrochloride (0.004 M) in H2O and
sulphanilamide 0.06 M (150 UL) in H3PO4 0.03 M, vol. 1:1] was
added. After incubation at 37 1C for 45 min, the reaction was
transferred to a microplate. Nitrite concentrations were estimated
by interpolation from a standard curve of sodium nitrite (0–
150 ıM) by colorimetric measurements at 540 nm in an ELISA
plate reader (OrganonTecknika, Roseland, NJ, USA). Results were
expressed as IM and the experiments were done in duplicate
2.6. Determination of anti-nociceptive effect of Chenopodium
ambrosioides (L)
2.6.1. Algogen-induced nociception in mice
The procedure for producing phgogen-induced nociception in
mice was similar to that described previously (Mattos et al.,
2006). Twenty microlitres of PGE2 (3 nmol/paw), formalin (FORM,
2.5%), BK (10 nmol/paw), or CAP (1 nmol/paw), diluted in PBS
solution, were injected intra-plantarly (i.pl.) under the ventral
surface of the right hindpaw. The animals were treated with EE
(150, 300 and 500 mg/kg, p.o.), or 0.9% saline solution (negative
control, p.o.) 1 h before injection of phlogistic substances. A
mirror was placed behind the chamber to enable unhindered
observation of the phogogen-injected paw. The animals were
placed individually in transparent glass cylinders 20 cm in dia-
meter, serving as observation chambers. They were observed
individually for 15 min after PGE2 injection, 10 min after CAP
and BK injection. The amount of time spent licking the injected
paw, timed with a chronometer, was considered to be indicative
of nociception. In the experiments with FORM, two distinct
phases of intensive licking or biting activity were identiﬁed: an
Fig. 1. Structure of monoterpenes ascaridole (1) and 1,2,3,4-tetrahydroxy-p-
menthane (2).
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(0–5 and 15–30 min after FORM injection, respectively).
2.7. Determination of wound healing effect of
Chenopodium ambrosioides (L)
2.7.1. Induction of ulcerative process (skin wound healing)
The methodology adopted was based on Cross et al. (1996) with
several modiﬁcations. On the day surgery, the rats were anaes-
thetised with a mixture of ketamine (100 mg/kg) and xylazine
(20 mg/kg) intra-peritoneally (i.p.). After conﬁrmation of deep anaes-
thesia, the hair on the back of the animal was manually removed
using a razor. The wound area was demarcated by a square
(2020mm2) on the distal portion of the back of the animal.
Immediately after the complete withdrawal of the skin, the
animals were placed in the ‘squat’ (‘crouching’)position, the
perimeter of the wound was cleaned, and approximately 0.7 g
of ointment base crude EE of Chenopodium ambrosioides (L)
(PEGþEE) at concentrations of 1%, 3% and 5% was applied
topically to one group. The ointment base was applied to one
group, and one group (negative control) received no treatment.
The animals were treated twice daily for 19 days, the wound area
was measured from days 1–19 before each treatment until the
wound healed completely in the negative control. Each wound
was measured in triplicate using a transparent sheet, for which
the extension of the wound and an average was calculated for
each measurement. The drawings of the measures were scanned
to a computer using a ﬂatbed scanner. After capturing of the
images, the area in mm2 wounds was calculated with the help of
the computer programme Image Js 1.3.1 (NIH, EUA) software.
2.8. Motor function assay: rota-rod
To evaluate the possible non-speciﬁc muscle-relaxant or
sedative effects of EE, mice were tested in the rota-rod test,
which was used to measure motor performance (Duham and
Miya, 1957). The apparatus (Rota Rod/ RS, LE-8500, series 1218/06,
Leticia Scientiﬁc Instruments) consisted of a bar with a diameter of
2.5 cm, sub-divided into six compartments by disks, 25 cm in
diameter. The bar rotated at a constant speed of 15 rpm. The mice
were previously selected, eliminating those mice that did not
remain on the bar for two consecutive periods of 60 s. On the
day of the experiment, animals were treated with the EE (150, 300
and 500 mg/kg, p.o.) and vehicle (saline), 1 h before undergoing the
test. The animals were assessed at the time 30, 60, 120 and
180 min after the treatment. The results were expressed as time
(s) in which the animals remained on the rota-rod apparatus. The
maximum time used was 60 s.
2.9. Body temperature measurement
Body temperature was measured using a commercially avail-
able digital thermometer (B & D, NJ, USA), which was gently
inserted (0.5 cm) into the mouse rectum. Temperature measure-
ments were performed in a temperature-controlled room
(22 1C72 1C), between 1500 and 1700 h. Temperatures were
recorded before any treatment and 30, 60, 120 and 180 min after
the treatment with EE of Chenopodium ambrosioides (L) (150, 300
and 500 mg/kg, p.o.) or vehicle (saline). This test was performed
according to Ansonoff et al. (2006).
2.10. Statistical analysis
Statistical analyses of results were performed by middle
analysis of variance (ANOVA) of the one-and two-way test for
multiple comparisons, using the Dunnet, Newman-Keuls, Tukeyand Bonferroni methods when appropriate. The results are
presented as mean7standard error of mean, except DI50
(corresponds to doses of extracts that reduced the response to
50% in relation the control group), which were presented with
geometric means accompanied by their respective conﬁdence
limits (95%). The percentages of inhibition were cited as mean7-
standard error of the mean difference (in %) between the areas on
the curves obtained for each individual experiment relative to the
corresponding control group. p-Values less than 0.05 (po0.05)
were considered indicative of signiﬁcance. All the analyses men-
tioned above were performed using the GraphPadInstats or
GraphPad PRISMs (GraphPad Software, San Diego, CA).3. Results
3.1. Phytochemical analysis
The phytochemical analyses with EE of leaves and stems of
Chenopodium ambrosioides (L) allowed the isolation of monoter-
penes ascaridole (1) (yield of 369 mg, 0.089% in relation to dry
plant) and 1,2,3,4-tetrahydroxy-p-menthane (2) (yield of 188 mg,
0.045% in relation to dry plant) (Fig. 1). Other two monoterpenes
were detected but have not been identiﬁed yet. The compounds
were identiﬁed by comparison of 1H and 13C NMR data with
previously published data from Cavalli et al. (2004).
3.2. Determination of anti-inﬂammatory effect of Chenopodium
ambrosioides (L)
3.2.1. Effect of Chenopodium ambrosioides (L) in ear oedema
induced by different phlogistic agents
In the ear oedema assay, it was observed that treatment with
cream containing the EE signiﬁcantly (F(4.25)¼104.6, po0.01)
inhibited the ear oedema induced by croton oil in all concentrations
when compared with control (base polawax; Fig. 2A). The EE extract
and the positive control, dexamethasone, also inhibited the
capsaicin-induced oedema (F(4.25)¼106.6, po0.01; Fig. 2B). The
same pharmacological proﬁle was observed in ear oedema induced
by AA (Fig. 2C). The treatment of animals with cream containing EE
of plant (1%, 3% and 5%) and dexamethasone produced signiﬁcant
decrease of ear oedema (F(4.25)¼272.4, po0.01).
3.2.2. Effects of Chenopodium ambrosioides (L) on paw oedema
induced by different phlogistic agents
Fig. 3 shows the anti-oedematogenic activity of Chenopodium
ambrosioides (L). The treatment with EE (150–500 mg/kg) signiﬁ-
cantly inhibited the paw oedema induced by carrageenan in a
dose-dependent manner (F(4.24)¼9.5, po0.01). This effect is
prolonged by 48 h, indicating a long-lasting effect (Fig. 3A1 and
A2). In addition, this extract at all doses was also able to inhibit
the oedema induced by PGE2 (Fig. 3B1 and B2) (F(4.12)¼10.9,
po0.01); SP (F(4.20)¼4.0, po0.01) (Fig. 3C1 and C2), and BK
Fig. 2. Inhibitory effects of the cream base of EE of Chenopodium ambrosioides (L)
(1%, 3% and 5%) on the ear oedema induced by different phlogistic agents (panel A:
croton oil (2.5%/ear), panel B: capsaicin (250 mg/ear), panel C: arachidonic acid
(2 mg/ear). Control: (animals treated only with base), DEX: animals treated with
dexamethasone (0.1%). Each column represents the mean of six animals and the
vertical bars the SE. Asterisks denote statistical differences compared with
controls (**po0.01). ANOVA was performed, followed by the Dunnett test. (%)
represents the inhibition values of inﬂammatory process.
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similar to those achieved with treatment with indomethacin
(10 mg/kg), and the IMs calculated were 56% for oedema induced
by carrageenan, 55% for oedema induced by PGE2, 62% for induced
by SP and 60% for oedema induced by BK (Fig. 3).3.2.3. Carrageenan-induced pleurisy
3.2.3.1. Effects of Chenopodium ambrosioides (L) on cellular
inﬁltration. The treatment with EE (150–500 mg/kg) caused a
signiﬁcant decrease in leucocyte inﬂux (Fig. 4A) in a dose-
dependent manner (F(5.36)¼643.8, po0.01) when administered
1 h before carrageenan. This reduction was attributed to
inhibition of mononuclear cells (Fig. 4B) of a dose-dependent
manner (F(5.36)¼9.8, po0.01). The treatments also reduced the
inﬂux of neutrophils in a dose-dependent manner (F(5.36)¼102.9,
po0.01) (Fig. 4C). The animals treated with indomethacin
(10 mg/kg) signiﬁcantly decreased leucocytes, monocytes and
neutrophils (po0.01) (Fig. 4A–C).3.2.4. Effects of Chenopodium ambrosioides (L) on myeloperoxidase,
adenosine-deaminase activities and the levels of NO and TNF-a
Fig. 5A shows that the treatment with oral EE 1 h before and
4 h after carrageenan injection statistically inhibited the activity
of myeloperoxidase (MPO) (F(5.18)¼28.3, po0.001) in the doses of
300 and 500 mg/kg. A similar effect was also observed, in which
ADA activity decreased at the dose of 500 mg/kg of EE
(F(5.18)¼35.5, po0.05; Fig. 5B). Fig. 5C shows that EE (300 and
500 mg/kg) statistically promoted (F(5.24)¼47.3, po0.001) reduc-
tion in NO levels, and Fig. 5D demonstrates that the extract
signiﬁcantly inhibited (F(5.18)¼45.4, po0.001) the production of
TNF-a in pleural ﬂuid after carrageenan injection at the doses of
300 and 500 mg/kg. The animals treated with indomethacin were
inhibited in MPO, ADA, NO and TNF-a, (po0.001) activities.3.3. Determination of anti-nociceptive effect of
Chenopodium ambrosioides (L)
3.3.1. Algogen-induced nociception in mice
The results demonstrate that the EE caused a pronounced anti-
nociceptive effect (Figs. 6 and 7). The pre-treatment with the extract
was able to signiﬁcantly reduce both phases of nociception (neuro-
genic and inﬂammatory) induced by FORM in all doses used. In the
ﬁrst phase of nociception, the calculated ID50 values were 284.1
(184.4–437.8) mg/kg. In the second phase of the nociception, EE and
indomethacin produced inhibition of process pain induced by
formalin (Fig. 6A and B). In this experiment, also observed the
anti-oedematogenic effect of EE (Fig. 6C). The results also showed
signiﬁcant anti-nociceptive effects in the pain model induced by
PGE2, (F(3.20)¼18.5, po0.01). The calculated ID50 as of 298.1 mg/kg
(260.5–341.0 mg/kg) (Fig. 7A). We also observed a signiﬁcant
inhibition of the nociceptive response induced by CAP in the
treatment at doses of 300 and 500 mg/kg (Fig. 7B), and ID50 of
470.3 mg/kg (335.8–658.7 mg/kg). However, in nociception induced
by BK, pre-treatment with EE inhibited the nociceptive response
(F(3.20)¼3.6, po0.05) with only the highest dose tested (500 mg/kg).3.4. Effects of Chenopodium ambrosioides (L) in the cutaneous
wound healing
The macroscopic analysis of skin wounds in animals treated
with EE showed the evolution of tissue repair and the absence of
bleeding and purulent secretions on different days of evaluation,
when compared to other groups. In the analysis of lesion size to
evaluate wound healing and repair, a signiﬁcant difference was
observed between the groups treated with PEG (po0.05) and
PEGþEE (po0.05) in relation to the control (untreated group) on
days 7, 14 and 19 after injury induction, with recovery to the
injured area (Table 1 and Fig. 8).
Fig. 3. Effects of the treatment with EE of Chenopodium ambrosioides (L) (150, 300 and 500 mg/kg, v.o.) on the paw oedema induced by different phlogistic agents (panel A1
and A2: Cg, panel B1 and B2: PGE2, panel C1 and C2: SP, panel D1 and D2: BK). A2, B2, C2 and D2 represent the area under curve (UAC), calculated using the entire time
course of each experiment and reported as mean7SE of inhibitions obtained for each individual experiment. Control (animals treated only with saline solution),
IND¼animals treated with indomethacin (10 mg/kg, p.o.) plus phlogistic. Each point represents the mean of six animals and bars the SE. Asterisks denote statistical
difference compared with control (**po0.001). Signiﬁcant differences determined by ANOVA complemented with Bonferroni test. (%) represents the inhibition values of
inﬂammatory process.
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The treatment of animals with EE of Chenopodium ambrosioides (L)
(150–500mg/kg) did not show any signiﬁcant alterations in motor
performance or body temperature compared to the control group
(p40.05) (results not shown).4. Discussion
The search for new drugs that effectively interfere with
inﬂammation and painful processes is currently of great rele-
vance. Efforts have been made to discover and develop new and
promising anti-inﬂammatory and analgesics from natural sources
Fig. 4. Effects of treatment with EE of Chenopodium ambrosioides (L) (150–500 mg/kg, p.o.) on the inﬂammation induced by carrageenan (Cg, 300 mg/cavity) in the mouse
pleurisy model. Effects of Chenopodium ambrosioides upon leucocytes (A), mononuclears (B) and neutrophils (C). Column dotted—animals that received distilled
waterþTween orally/intrapleural saline; column black—animals that received distilled waterþTween oral/intrapleural carrageenan (300 mg/cavity); hatched columns—-
treated animals orally with different doses of the EE (L) intrapleural carrageenan and white column—animals that received indomethacin 10 mg/kg, p.o./intrapleural
carrageenan. Each point represents the mean of six animals and bars the SE. Asterisks denote statistical difference compared with control (**po0.01). Signiﬁcant
differences determined by ANOVA complemented with Dunnett tests. (%) represents the inhibition values of treatments upon leucocytes (A), mononuclears (B) and
neutrophils (C).
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Brazilian population and in several regions of Central and South
America for therapeutic purposes includes Chenopodium ambro-
sioides (L.). This plant is used in folk medicine as a topical anti-
inﬂammatory (Lorenzi and Matos, 2002).
In the present study, ear oedema was induced by croton oil, AA
and CAP. Ear oedema induced by croton oil is used to evaluate the
anti-inﬂammatory activity of compounds that act on the acute
phase of inﬂammation. This model allows inhibitors of the
biosynthesis of prostaglandins and leukotrienes, acting on key
enzymes in the cascade of biosynthesis of these mediators,
ciclooxigenase(COX) and lipoxygenase(LOX) (Terraciano et al.,
2006). The croton oil contains the compound 12-O-tetradecanoil-
forbol-13-acetate, known as TPA, which induces an acute inﬂam-
matory response, characterised by vasodilation and oedema
formation. This response occurs in the ﬁrst two hours, followed
by increased thickness of the ear. The result is inﬁltration of
polymorphonuclear leucocytes to the tissue that peaks in thesixth hour, and from then on tends to decrease, reaching basal
values after 24 h of induction (Andu´jar et al., 2010). AA, when
applied topically, produces an immediate increase in vascular
permeability, resulting in oedema, which is associated with a
marked increase in levels of prostaglandins (PGE2, PGF2a), TXA2,
LTB4, and LTC4 (Nonato et al., 2011). CAP is an alkaloid found in
the species Capsicum annuum that produces an immediate neuro-
genic inﬂammatory response characterised by vasodilation,
increased blood ﬂow and oedema formation by plasma leakage,
in addition to pain (Kalil-Gaspar, 2003). The results of this study
indicate that EE produced a pronounced inhibition of the ear
oedema, similar to dexamethasone.
Phytochemical investigations on the species of the Chenopodium
genus revealed a wide variety of terpenes, steroids, saponins and
ﬂavonoids (Kokanova-Nedialkova et al., 2009).Chenopodium ambro-
sioides (L) has high levels of monoterpenes, mainly in its essential
oil (Monzote et al., 2009). In the analysed extract the mono-
terpenes ascaridole and 1,2,3,4-tetrahydroxy-p-menthane were
Fig. 5. Effects of the treatment with different doses of EE of Chenopodium ambrosioides (L) (150–500 mg/kg, p.o.) on inﬂammation induced carrageenan (Cg, 1%) in the
model of pleurisy. Effects of EE on myeloperoxidase (A), adenosine deaminase (B), levels of nitric oxide (C) and TNF-a (D). Sal¼control (animals treated only sterile saline),
Saline¼animals treated with carrageenan, Indo¼animals treated with indomethacin (10 mg/kg, p.o.). Each group represents the mean of 8–10 animals and vertical bars
the SE. Signiﬁcant differences determined by ANOVA complemented by Dunnett or Student test. *po0.05, **po0.01, ***po0.001 compared with Cg. (%) represents the
inhibition values of treatments upon myeloperoxidase, adenosine deaminase, levels of nitric oxide and TNF-a.
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2004). Ascaridole is the most abundant substance in the Chenopo-
dium genus (Dembitsky et al., 2008). It was obtained as a major
component of the essential oil of Chenopodium ambrosioides (L)
(Cavalli et al., 2004). Ascaridole shows analgesic, sedative and anti-
fungal effects (Olajide et al., 1997). The 1,2,3,4-tetrahydroxy-p-
menthane has only been isolated from the extract from the leaves
of Chenopodium ambrosioides (L) in Egypt and it was detected in the
essential oil of this species (Cavalli et al., 2004). No records of
activity were found for this compound. This data suggests that
these compounds or other phytochemicals present in this extract
may inhibit the formation of inﬂammation process mediators, and
this effect is independent of the phlogistic agent used.
EE can produce its anti-oedematogenic effect by inhibiting the
synthesis of eicosanoids and cytokines, in which PGE2 and TNF-a
would be the main oedematogenic mediators (Saraiva et al.,
2011). These anti-inﬂammatory effects with cream containing
the extract validate in part its popular use and demonstrate its
efﬁcacy when it is used topically.
Another model used to evaluate the anti-inﬂammatory activity
of EE was the model of paw oedema induced by different
phlogistic agents. Paw oedema induced by carrageenan in mice
involves a biphasic inﬂammatory response. The ﬁrst phase (0–1 h)
is associated with the release of various mediators such the
release of histamine, serotonin, SP and cytokines, as well as
TNF-a, IL-1b, IL-2 and IFN-g with the release of vascular perme-
ability (De´ciga-Campos et al., 2007). The second phase (1–6 h) is
related to the elevated production of prostaglandins derived from
release of free radicals and the induction of cyclooxygenase
(Panthong et al., 2004). In this study, the results show that EE of
Chenopodium ambrosioides (L) effectively inhibited the oedemainduced by carrageenan at all doses (150–500 mg/kg, p.o.),
corroborating the results obtained by Ibironke and Ajiboye
(2007), who reported that treatment with the methanol extract
of leaves of Chenopodium ambrosioides (L) inhibits the paw
oedema induced by carrageenan. It can be inferred that the
anti-inﬂammatory action of the extract may be due to inhibition
of mediators involved in events such as histamine, BK, SP and
prostaglandins. To investigate this hypothesis, we evaluated the
effect of EE on the model of paw oedema induced by mediators
released during the inﬂammation process induced by Cg.
SP, a neuropeptide, is involved in inﬂammatory processes and
also in the regulation of pain threshold (Smith et al., 2010).
During inﬂammation, the SP induces the release of mediators,
cytokines, AA derivatives, histamine and oxygen radicals, which
potentiate tissue damage and stimulate the recruitment of leu-
cocytes, amplifying the inﬂammatory response (Bhatia, 2010).
Another inﬂammatory mediator used was BK, which is one of
the main representatives of the class of cytokine. BK plays an
important role in inﬂammation, promoting events such as vaso-
dilatation, increased vascular permeability and increased produc-
tion of eicosanoids, and in pain, it promotes the sustainment of
the painful stimulus (Ferreira et al., 2000).
The present study also investigated the effect of EE on the paw
oedema induced by PGE2. PGE2 is synthesised in substantial
amounts at the sites of inﬂammation, and it acts as a potent
vasodilator, inducing the production of various chemo-attrac-
tants, such as leucocytes and pro-inﬂammatory cytokines includ-
ing IL-1 and TNF-a (Kaur et al. 2004). This mediator also
participates in acute pain, sensitising the nerve endings of
nociceptive ﬁbres Ad and C through its receptor EP1 (Rady
et al., 2001). It can be observed in our study that treatment with
Fig. 6. Effects of the treatment with EE of Chenopodium ambrosioides (L)
(50–500 mg/kg, p.o.) and indomethacin (10 mg/kg, p.o.), (A) neurogenic phases
(0–5 min), (B) inﬂammatory phases (15–30 min) and (C) oedema, on the
formalin-induced analgesia. Each column represents the mean of six animals
and vertical bars the SE. Asterisks denote statistical signiﬁcance (**po0.01)
compared with control. ANOVA was performed, followed the Dunnett test. (%)
represents the inhibition values of treatments on pain induced by formalin.
Fig. 7. Effect of the treatment with EE of Chenopodium ambrosioides (L) (150–
500 mg/kg, p.o.) on the nociceptive response induced by PGE2, (A), CAP (B) and BK
(C) in mice. Each column represents the mean of six animals and vertical bars the
SE. Asterisks denote statistical signiﬁcance (*po0.05, **po0.01) compared with
control. ANOVA, followed the Dunnett test. (%) represents the inhibition values of
treatments on pain induced by PGE2, CAP and BK.
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which indicates a broad spectrum of inhibition of various med-
iators involved in inﬂammation.To obtain new results on the anti-inﬂammatory effect of
Chenopodium ambrosioides (L) another classic model of inﬂamma-
tion was used: carrageenan-induced pleurisy. The mouse
model of pleurisy involves the participation of several cell types
Table 1
Cicatrization speed of the animals subjected to dorsal skin lesion in the days (1, 7, 14 and 19) after daily treatment
with ointment 5% of EEB.
Time (days) (mm/d) 1 7 14 19
Control 3108.407504.20 2054.2071180.01 933.00787.13 97.8074.36
PEG 2757.257825.74 1857.5071042.54 794.757211.96 61.7573.06
PEGþEEB 5% 2260.407720.12 1609.207182.69nn 611.00755.11n 27.6074.17nn
Control—animals no treatment, PEG-ointment base, PEGþEEB—ointment with EEB of Chenopodium ambrosioides (5%).
Asterisks denote statistical signiﬁcance (npo0.05, nnpo0.01) compared with control. ANOVA, followed the Dunnett
test.
Fig. 8. Macroscopic analysis of skin lesions in the animal, 1, 7, 14 and 19 days with daily treatment with PEG base and EEB ointment to 5% from the injury. Male Wistar rats
(n¼5/grupo) underwent single lesion incisional of 20 mm.
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idase, adenosine-deaminase and products of pathways that are
stimulated by nitric oxide synthase (iNOS) have been implicated
in several aspects of the inﬂammatory cascade including plasma
exudation and cell migration. In this context, Saleh et al. (1996)
previously demonstrated in this same model of inﬂammation that
MPO activity and nitrate/nitrite (NO) levels signiﬁcantly increase
4 h after carrageenan-induction of inﬂammation in the mouse
model of pleurisy. In our study, EE was effective in producing
signiﬁcant inhibition of the inﬂammatory response with respect
to leucocyte migration in relation to neutrophils and mono-
nuclear cells to inﬂammatory site.
ADA is essential for the proliferation and differentiation of
lymphoid cells, particularly T cells and the maturation of mono-
cytes, thus possessing an important function in the immune
system in inﬂammatory processes (Antonioli et al., 2008). The
results showed that EE was effective in inhibiting the enzyme
activity; this effect can contribute to limiting the inﬁltration of
leucocytes and subsequent cell damage.
Nitric oxide is another important pro-inﬂammatory mediator
involved in the exudation and leucocyte migration in inﬂammatory
process (Abramson, 2008). The results show that EE signiﬁcantly
inhibited NO levels. This effect suggests that the anti-inﬂammatoryeffect of this plant may also be associated with the inhibition of
reactive oxygen species including the superoxide radical (O2
),
hydrogen peroxide (H2O2) and the hydroxyl radical (OH
d). This
study also tested the effect of the extract on the cytokine TNF-a.
TNF-a is a key cytokine in the development of pleural inﬂamma-
tion, which increases the production of chemokines by endothelial
cells (Cailhier et al., 2006).
In summary, our results demonstrate that EE exhibits anti-
inﬂammatory effects in important and different animal models of
inﬂammation, and its effects extend to both vascular and cellular
events of the inﬂammatory process.
Pain is also one of the signs of the inﬂammatory process; we
assessed whether EE showed anti-nociceptive effects. Since EE
was effective in inﬂammation induced by mediators such as BK
and PGE2, which also participate in the pain process, we assessed
whether the treatment of animals with EE could inhibit the pain
process induced by PGE2 and BK and also by CAP and FORM. The
results demonstrate that EE was statistically able to inhibit the
pain induced by PGE2 suggesting their participation in acute pain.
In the model of nociception induced by BK, it was observed that
only the dose of 500 mg/kg decreased pain threshold (Mattos
et al., 2006). The anti-nociceptive effect of the extract was also
observed in the model of pain induced by CAP. It is inferred that
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model (Santos and Calixto, 1997), suggesting the possible action
by the extract in pain of neurogenic origin.
The formalin-induced pain model causes nociceptor stimula-
tion, resulting in typical animal behaviours such as licking and/or
biting the paw injected with this agent. This model evaluates two
distinct phase of nociception, the ﬁrst of neurogenic origin (occurs
chemical stimulation of nociceptors of sensory afferent ﬁbres
mainly type C) (Hunskaar and Hole, 1987) and the second of
inﬂammatory origin [production of multiple events mediated by
release of inﬂammatory mediators (PGs, NO, HIS, BK) (Sulaiman
et al., 2010). Our results show that the EE of Chenopodium
ambrosioides (L) was able to signiﬁcantly inhibit both phases
(neurogenic and inﬂammatory) in the formalin test, in addition to
inhibiting oedema. The reference drug, a COX inhibitor used for
comparison, was effective only in the second phase. It has been
documented that non-steroidal anti-inﬂammatory and analgesic
medications are effective in the second phase of the formalin test,
which is related to the inhibition of prostaglandin synthesis in the
modulation of pain (Hunskaar and Hole, 1987). The plant under
study is used in folk medicine as a healing agent. We attempted to
analyse this effect using a wound healing method. This method is
reliable and low cost (Martins et al., 2006). During the experi-
ments, no signs of infection were observed in the group treated
with the Chenopodium ambrosioides (L) ointment; this can be
explained by its anti-microbial and anti-inﬂammatory properties,
conﬁrmed by this study and previous studies with this plant
(Delespaul et al., 2000; Ibironke and Ajiboye, 2007), inhibiting
both the inﬂammatory and infectious process of the event. The
treatment with EE on the injured tissue produced an evolutionary
tissue repair when compared to the control group (untreated). It
is believed, based on previous data, that the injury was quickly
ﬁlled with clots and ﬁbrin, producing the formation of crust
isolating tissue from the external environment (Faleiro et al.,
2009), but more advanced studies are needed to verify such data.
The results showed that treatment of animals with EE 5% oint-
ment accelerated the process of repair and healing when com-
pared to the control group.
In the present study, two additional pharmacological models
were used to investigate possible adverse effects of EE that could
interfere with the observed results or derail the use of the plant as
an alternative therapy. The ﬁrst model was the rota-rod test and
was used to exclude the possibility that EE caused motor relaxa-
tion and sedation (Sulaiman et al., 2010). EE, in all doses used, did
not induce any interference in the motor performance of the
animals. This model used was the test of body temperature. It has
been reported that analgesic substances can induce hypothermia
(Alfonsi et al., 2004). In animals treated with EE, no changes in
body temperature were observed. The literature on Chenopodium
ambrosioides (L) reports that the essential oil of the plant exhibits
toxicological effects at high doses and prolonged use (Montoya-
Cabrera et al., 1996). However, reports in the literature are
contradictory. In Brazil, the plant is used in food for the treatment
of helminthic infestations, but no toxic effects have been asso-
ciated with its use in this way (Kliks, 1985). In this study, the oral
doses used were lower than those used in toxicological testing by
Pereira et al. (2010). In addition, during the execution of the
experiments, no behavioural or physiological changes were
observed that may have indicate designs of intoxication.5. Conclusions
The results of this study conﬁrm and extend previous studies
on the anti-inﬂammatory and anti-nociceptive effects of
Chenopodium ambrosioides (L), identifying the mechanism of actionas the inhibition of mediators (BK, NO, SP, PGE2 and TNF-a) and
enzymes (MPO and ADA) involved in the inﬂammatory and pain
processes. Together, the results partially validate the popular use of
this plant for therapeutic use of inﬂammatory, pain and wound
healing processes.Acknowledgements
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